News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Australian Regulator Rejects Zeltia Group (18494051.MA)'s Cancer Drug Yondelis



11/12/2010 6:59:01 AM

MADRID, Nov 12 (Reuters) - Spanish drug company Zeltia's (ZEL.MC) application to register its key Yondelis anti-cancer drug in Australia has been rejected, the country's Advisory Committee on Prescription Medicines (APCM) said in a report.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES